Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.
about
Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancerImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesCD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients.Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.Pathologic patterns of interleukin 10 expression--a review.IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanismOligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets.MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression.Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Association of IL10 -819C>T and -592C>A Polymorphisms with Non-Hodgkin Lymphoma Susceptibility: Evidence from Published StudiesImmunotherapy and immunoprevention of cancer: where do we stand?Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours.PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κBThe SNP at -592 of human IL-10 gene is associated with serum IL-10 levels and increased risk for human papillomavirus cervical lesion development.Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancerIn Thyroidectomized Thyroid Cancer Patients, False-Positive I-131 Whole Body Scans Are Often Caused by Inflammation Rather Than Thyroid Cancer.The impact of T-cell immunity on ovarian cancer outcomes.Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy.Wnt5A exerts immunomodulatory activity in the human ovarian cancer cell line SKOV-3.The expression of interleukin-10 in patients with primary ovarian epithelial carcinoma and in ovarian carcinoma cell lines.Myeloid suppressor cell-associated immune dysfunction in CSA1M fibrosarcoma tumor-bearing mice.IL-1 and TNF-alpha but no IL-2 expression is found in squamous cell carcinomas of the head and neck by RT-PCR.GM-CSF gene expression and protein production in human colorectal cancer cell lines and clinical tumor specimens.Endogenous interleukin-10 in inflammatory disorders: regulatory roles and pharmacological modulation.Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro.Expression of Cytokines Interleukin-2, Interleukin-4, Interleukin-10 and Transforming Growth Factor β in Gastric Adenocarcinoma Biopsies Obtained from Mexican PatientsExpression of interleukin 10 in human melanoma.Functional characterization of human T cells immortalized by oncogene transfection.The paradox of IL-10-mediated modulation in cervical cancer.PC-3 prostate carcinoma cells release signal substances that influence the migratory activity of cells in the tumor's microenvironment.Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes.Immunomodulatory effects of low dose cis-Diaminedichloroplatinum (cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer.Infiltrating CD8+ T lymphocytes, natural killer cells, and expression of IL-10 and TGF-beta1 in chemically induced neoplasms in male Wistar rats.Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: evidence for defective processing in tumor cells.Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects.Inflammatory breast cancer: High incidence of GCC haplotypes (-1082A/G, -819T/C, and -592A/C) in the interleukin-10 gene promoter correlates with over-expression of interleukin-10 in patients' carcinoma tissues.
P2860
Q24802483-67859B6D-1FB4-4AC1-901C-93C164481656Q26798402-FC8E2D5A-88F6-4C3E-87DA-59ABA0BBE519Q34154427-969C2778-AD6C-498B-A451-41B7F1FDEF64Q34557233-F3000066-796F-49BD-B6E6-9A178267A708Q34667904-89E82B8B-24D5-45F6-9ADB-72D5010F1152Q34825943-F6445EF3-6678-48C4-8F9D-3648D0F3CD0BQ34877563-AAFD9B11-2FC9-4828-A4D6-35562661BC6FQ35748965-53C9BB4F-B790-4F8C-BB30-18551F712DEAQ35799094-86DA5303-07C7-4292-95A9-3330DAA0BEFFQ35856831-ABA57692-BD1B-43CA-BB86-F9F83B55029DQ36150524-C347032C-04A9-44DC-BB31-161840F73E35Q36364150-91002F08-9D6C-4C1F-A808-108CF193B8F3Q36421948-FAD4D8BE-369B-4B0E-9C7C-95F9B0102EC6Q36471523-7694D0FE-1DBF-4DC5-BA43-F16FB56B262EQ36555779-A3559CF1-B801-48C9-B222-B2F3B1EBAC07Q36621847-7EFEC381-A034-4FD5-A520-5ED8C8DB55CFQ36645660-62CE47F3-A208-4594-B62B-9271819178E1Q37118142-34B55A0C-FFEB-4833-AFD9-FD00D1FE05B6Q37680355-C00DA98A-C29E-4472-8FB4-A0502AFDEA8DQ37693818-AE80F309-90DB-427A-9DE5-19AA6644742FQ37964608-2AEF0DEC-E89A-49F9-95AC-B871C77CE2DFQ38828227-42E124CA-AD57-4EE1-A831-1457966546CFQ40115028-3FC37CB1-7AD1-48ED-82E9-ED42D946E5AEQ40145995-7E68E6E4-DC4A-4F11-93DC-1AF7B9FE6897Q40958245-ED885C3A-65C5-4750-9FB3-4CBCD01679C6Q41025628-2AA4F21B-41B1-4E5A-A015-0834DA228CE9Q41200759-610847E5-02DF-4EE8-AB2C-23A05F7A7ECDQ41264607-26DE771B-F427-4460-A700-6D67F1D58D84Q41813201-88AD9DAA-60A6-4963-9A5A-D9C9BE984B3AQ42067641-A70369A4-69A6-4286-A452-5AB8CDD171CEQ42110173-C7D249EC-981B-4379-9AA5-F18086FEFB19Q42571106-34461EDE-F129-4782-B452-233A81AD4A71Q42650190-FB77AD2F-FC1E-42FA-AEAC-011AEBBDEA7CQ43201293-AD16BC3A-B30C-42B6-8D3A-9A41170039FFQ43922180-972BC2BA-2F03-4318-88C4-BDF95F610766Q45189729-E60A1FC2-8EE4-4755-917E-D80934771F8FQ45885053-82747215-4365-4040-9884-3CFC5A7E1624Q47901983-30FE9C2D-9DE4-4D79-8ED6-DFFCD10F080FQ47912619-2F55107C-A777-49CA-911A-F5920B5226AAQ50547068-07701537-CB09-474A-88E1-184A244E2F35
P2860
Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective expression of interl ...... or in ovarian cancer biopsies.
@en
Selective expression of interl ...... or in ovarian cancer biopsies.
@nl
type
label
Selective expression of interl ...... or in ovarian cancer biopsies.
@en
Selective expression of interl ...... or in ovarian cancer biopsies.
@nl
prefLabel
Selective expression of interl ...... or in ovarian cancer biopsies.
@en
Selective expression of interl ...... or in ovarian cancer biopsies.
@nl
P2093
P2860
P921
P356
P1476
Selective expression of interl ...... or in ovarian cancer biopsies.
@en
P2093
Kiessling R
P2860
P304
P356
10.1073/PNAS.89.16.7708
P407
P577
1992-08-01T00:00:00Z